Roundup Cancer Legal News Articles & Interviews

San Diego, CA A new study, conducted by researchers at the University of California San Diego School of Medicine, suggests an association between glyphosate, the active ingredient in Monsanto’s weed killer Roundup, and nonalcoholic fatty liver disease in human beings.

Oakland, CA The jury in Pilliod v. Monsanto Co heard evidence that was not presented in previous Monsanto glyphosate lawsuits. It may have prompted the record-breaking $2 billion award, and the information may be central to the more than 13,000 Roundup lawsuits still pending.

Oakland, CA The jury in Pilliod v. Monsanto Co, the third Monsanto glyphosate lawsuit to go to trial, awarded Alva and Alberta Pilliod $55 Million in compensatory damages and a staggering $1 billion each (that’s $2 billion) in punitive damages for their Roundup-linked cancers. This is reportedly the largest award personal injury award this year and the eighth largest in US history. Although the punitive portion of the award will likely to be reduced under U.S. Supreme Court precedent, the trend in jury sentiment is clear.

Oakland, CA Pilliod v. Monsanto Co., the latest a Monsanto glyphosate lawsuit to go to trial, has focused squarely on the quality of the scientific evidence. Relying on expert testimony, counsel for Alberta and Alva Pilliod has accused Monsanto of outright fraud in securing regulatory approval for Roundup. Counsel for Monsanto has tried to undermine expert Charles Benbrook’s testimony by questioning his credentials.

San Francisco, CA On March 27, a jury in Hardeman v. Monsanto Co., a Monsanto glyphosate lawsuit awarded Edwin Hardeman more than $80 million. A third trial, Pilliod v. Monsanto Co. is well under way. Allegations have flown about untoward jury influence, and U.S. District Judge Vince Chhabria has begun to push the parties’ attorneys toward settlement. Things are now moving very fast in the world of Monsanto glyphosate lawsuits.

San Francisco, CA On March 19, the jury in Hardeman v. Monsanto Co. unanimously found that RoundUp was a substantial factor in causing Edward Hardeman’s non-Hodgkin's lymphoma. This first phase of Hardeman’s Monsanto glyphosate lawsuit focused solely on scientific facts relevant to causation. The second phase will determine corporate liability, based on alleged corporate misconduct by company representatives. Monsanto and its corporate parent, Bayer AG of Germany face more than 11,000 Monsanto glyphosate lawsuits over alleged RoundUp cancer.

Atlanta, GA: “My husband and father-in-law were both diagnosed with Non-Hodgkin lymphoma and they both sprayed the backyard with Monsanto’s Roundup,” says Veronica. (Because studies have continually linked the herbicide to that type of cancer, it also referred to as 'Monsanto cancer'.)

San Francisco, CA: August 10, 2018 was a bad day for Bayer and Monsanto executives. That was the day when San Francisco jurors determined that Monsanto’s (and now Bayer’s) RoundUp and Ranger Pro caused cancer in a former school groundskeeper who claimed his terminal cancer had been caused by the glyphosate-based weed-killers.

San Francisco CA: School groundskeeper DeWayne Johnson was diagnosed with non-Hodgkin's lymphoma in 2014 at the age of 42. He is the first cancer victim to take Monsanto (now owned by drug giant Bayer) to court. In August, Johnson was awarded $289 million but damages were later to reduced to $78 million. And the first out of more than 620 Monsanto cancer cases pending in federal litigation is set for February 2019, according to Reuters.

San Francisco, CA On October 11, 2018, San Francisco Superior Court Judge Suzanne Bolanos tentatively ruled that she would toss out the jury’s $250 million punitive damage award and schedule a new trial on that issue. The judge also suggested she may also drastically reduce the $39 million compensatory damage portion of the Monsanto glyphosate lawsuit award. The final ruling is due on October 22. The results of this trial are expected to have significant impact on the hundreds of Roundup cancer lawsuits now pending.